Expertise in
1
conditions

David Lorente

Downs Road, Surrey, 
Sutton Upon Derwent, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
1
conditions
Downs Road, Surrey, 
Sutton Upon Derwent, ENG, GB 

Overview

David Lorente practices practicing medicine in Sutton Upon Derwent, United Kingdom.

Mr. Lorente is highly rated in 1 condition, according to our data. His clinical expertise encompasses Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Orchiectomy, and Prostatectomy.

He is actively involved in clinical research, co-authoring 68 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Downs Road, Surrey, Sutton Upon Derwent, ENG SM25PT, United Kingdom
Other Locations
London, ENG, United Kingdom
Marsden, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

International Registry for Men With Advanced Prostate Cancer (IRONMAN)
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Enrollment Status: Recruiting
Publish Date: May 22, 2026
Intervention Type: Other
A Single Arm Phase I-II Multicenter Trial With Avelumab Plus Autologous Dendritic Cell Vaccine to Determine Safety and Preliminary Efficacy of the Combination in Pre-treated Mismatch Repair-proficient (MSS) Metastatic Colorectal Cancer Patients.
A Single Arm Phase I-II Multicenter Trial With Avelumab Plus Autologous Dendritic Cell Vaccine to Determine Safety and Preliminary Efficacy of the Combination in Pre-treated Mismatch Repair-proficient (MSS) Metastatic Colorectal Cancer Patients.
Enrollment Status: Completed
Publish Date: October 06, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

68 Total Publications

BRCA1/2 and homologous recombination repair alterations in high- and low-volume metastatic hormone-sensitive prostate cancer: prevalence and impact on outcomes.
BRCA1/2 and homologous recombination repair alterations in high- and low-volume metastatic hormone-sensitive prostate cancer: prevalence and impact on outcomes.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 14, 2025

Frequently Asked Questions about David Lorente

Is David Lorente a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. David Lorente is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does David Lorente participate in research or clinical trials?

Yes. David Lorente has published 68 articles and abstracts on conditions like Prostate Cancer. You can view a list of David Lorente's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lorente's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile